C. Gil

发表

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

G. M. Ortiz, D. Nixon, S. Bonhoeffer, 2001, AIDS.

Incidence of Non-A, Non-B Hepatitis after Screening Blood Donors for Antibodies to Hepatitis C Virus and Surrogate Markers

C. Gil, J. Sánchez-Tapias, J. Costa, 1991 .

Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.

Felipe García, M. Plana, A. Cruceta, 2005, The Journal of infectious diseases.

Persistent hepatitis C viremia after acute self‐limiting posttransfusion hepatitis C

C. Gil, J. Rodés, M. Bruguera, 1995, Hepatology.

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.

B. Clotet, J. Martinez-Picado, C. Brander, 2011, Vaccine.

CD31 Is Required on CD4+ T Cells To Promote T Cell Survival during Salmonella Infection

I. Henderson, C. Gil, A. Cunningham, 2011, The Journal of Immunology.

Hepatitis C virus infection among kidney transplant recipients.

C. Gil, J. Campistol, M. Bruguera, 1991, Kidney international.

Lymphoid tissue collagen deposition in HIV-infected patients correlates with the imbalance between matrix metalloproteinases and their inhibitors.

Antonio Martínez, Felipe García, M. Plana, 2011, The Journal of infectious diseases.

HIV-1 Upregulates Intercellular Adhesion Molecule-1 Gene Expression in Lymphoid Tissue of Patients With Chronic HIV-1 Infection

Antonio Martínez, Felipe García, C. Gil, 2007, Journal of acquired immune deficiency syndromes.

A therapeutic dendritic cell-based vaccine for HIV-1 infection.

B. Clotet, J. Martinez-Picado, J. Romeu, 2011, The Journal of infectious diseases.

Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence

E. Campo, Felipe García, J. Gatell, 2005, Modern Pathology.

Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.

C. Gil, J. Campistol, M. Bruguera, 1991, Transplantation proceedings.

Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients

Antonio Martínez, Felipe García, M. Plana, 2010, AIDS.

Adenosine deaminase enhances T‐cell response elicited by dendritic cells loaded with inactivated HIV

Felipe García, J. Gatell, C. Gil, 2009, Immunology and cell biology.

Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

Felipe García, M. Plana, M. Arnedo, 2006, Enfermedades infecciosas y microbiologia clinica.

A Dendritic Cell–Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication

B. Clotet, J. Martinez-Picado, B. Autran, 2013, Science Translational Medicine.

Effect of Mycophenolate Mofetil on Immune Response and Plasma and Lymphatic Tissue Viral Load During and After Interruption of Highly Active Antiretroviral Therapy for Patients With Chronic HIV Infection: A Randomized Pilot Study

Felipe García, M. Plana, M. Arnedo, 2004, Journal of Acquired Immune Deficiency Syndromes.

Felipe García Control of HIV-1 Replication Based Vaccine Elicits T Cell Responses Associated with − A Dendritic Cell

Felipe García, Brigitte Autran, Agathe León, 2012 .

Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8+ T Cell Responses in HIV-1-Infected Individuals

Felipe García, C. Gil, T. Gallart, 2011, PloS one.

Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I.

M. Plana, Á. Soriano, C. Vidal, 2001, AIDS.

Predictors of Tonsillar Tissue HIV-1 Viral Burden at Baseline and after 1 Year of Antiretroviral Therapy

Felipe García, G. Mestre, M. Plana, 2002, Antiviral therapy.

Lymphoid tissue viral burden and duration of viral suppression in plasma

Felipe García, M. Arnedo, C. Gil, 2001, AIDS.

Evaluation of the Roche COBAS® TaqMan® HIV-1 test for quantifying HIV-1 RNA in infected cells and lymphoid tissue.

Felipe García, C. Gil, T. Pumarola, 2011, Journal of virological methods.

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.

C. Gil, T. Pumarola, J. Miro, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

N. Navaratnam, Felipe García, J. Gatell, 2016, Immunology and cell biology.

Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.

C. Gil, H. Tillmann, I. Haro, 2010, Journal of medicinal chemistry.

Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption.

Felipe García, M. Plana, A. Cruceta, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mother-to-Infant Transmission of Hepatitis C Virus A Prospective Study

C. Gil, O. Coll, C. Fortuny, 1994 .

Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

Felipe García, M. Plana, M. Arnedo, 2006, Enfermedades Infecciosas y Microbiologia Clinica.

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

N. Navaratnam, Felipe García, J. Gatell, 2016, Immunology and cell biology.

E. Domingo, Felipe García, M. Plana, 2004, Journal of medical virology.